2019 annual financial data
Avalo Therapeutics 2019 Operating margin
Direct answer
Operating margin was -239.06%.
Operating income was -16,137,408 USD and net income was -16,072,547 USD.
Operating cash flow was -19,134,332 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,750,351 USD
- Operating income
- -16,137,408 USD
- Net income
- -16,072,547 USD
- Operating cash flow
- -19,134,332 USD